Research Progress on the Regulation and Mechanism of Borneol on the Blood-Brain Barrier in Pathological States: A Narrative Review Focused On Ischemic Stroke and Cerebral Glioma

Authors

Xinghua Tan
Ke Zhang
Wenyin Shi, Thomas Jefferson UniversityFollow
Zhihu Tang

Document Type

Article

Publication Date

10-22-2023

Comments

This article is the author's final published version in Translational Cancer Research, Volume 12, Issue 11, November 30 2023, Pg. 3198 - 3209.

The published version is available at https://doi.org/10.21037/tcr-23-1487. Copyright © Translational Cancer Research. All rights reserved.

Abstract

Background and Objective: The blood-brain barrier (BBB) serves as a dynamic, selective shield, safeguarding the central nervous system (CNS) by separating the brain from circulating blood, preserving its microenvironment, and ensuring stability. However, in the presence of brain pathology, drug delivery across the BBB and blood-tumor barrier (BTB) becomes challenging, hindering effective treatments. Borneol exhibits promise in bidirectionally modulating the BBB under pathological conditions, suggesting at potential clinical applications for related diseases. Our primary goal in this review is to investigate borneol’s potential clinical utility in bidirectionally regulating the BBB under pathological conditions.

Methods: The PubMed database, CNKI (China National Knowledge Infrastructure), Wanfang Data were searched to retrieve articles on animal experiments and cell-based research published from January 1, 2003, to May 1, 2023, using the following medical subject headings (MeSH) terms: borneol, blood-brain barrier, ischemic stroke, cerebral gliomas, anti-inflammatory. The search was limited to articles published in English and Chinese. In total, 86 articles were deemed eligible for inclusion in this study.

Key Content and Findings: The breakdown of the BBB is a key pathological process in ischemic stroke and cerebral glioma. When used alone, the lipophilic properties of borneol can reduce the permeability of the BBB and restore its normal function, thereby repairing brain damage and protecting brain tissue. Its specific protective effects may be related to inflammatory regulation mechanisms. The anti-inflammatory and protective effects of borneol can be used to improve and treat lesions caused by ischemic stroke and cerebral glioma. Furthermore, when combined with other drugs, borneol can accelerate the opening of the BBB, improve permeability through physiological processes, and enhance drug penetration and distribution in the brain without causing pathological damage to the brain.

Conclusions: This review summarizes the mechanisms by which borneol regulates the BBB and BTB in ischemic stroke and cerebral glioma, and discusses the potential clinical applications of borneol in the treatment of these diseases. It is believed that in the future, as research methods are refined, more effective and targeted therapies for cerebral glioma and ischemic stroke will be explored related to the protective mechanism of the BBB under pathological conditions with borneol alone or in combination with other drugs.

Recommended Citation

Tan, Xinghua; Zhang, Ke; Shi, Wenyin; and Tang, Zhihu, "Research Progress on the Regulation and Mechanism of Borneol on the Blood-Brain Barrier in Pathological States: A Narrative Review Focused On Ischemic Stroke and Cerebral Glioma" (2023). Department of Radiation Oncology Faculty Papers. Paper 186.
https://jdc.jefferson.edu/radoncfp/186

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Language

English